Canasa

Treatment of Ulcerative Proctitis

Canasa is prescribed for the treatment of active ulcerative proctitis in adults. Ulcerative proctitis is a localized form of ulcerative colitis that causes inflammation and sores in the lining of the rectum.

Symptom Management

This medication is used to manage and relieve the symptoms that occur during a flare-up of the condition. These symptoms often include:

• Rectal bleeding
• Pain or discomfort in the rectal area
• A frequent or urgent need to have a bowel movement
• Diarrhea

The active ingredient, mesalamine, works by reducing the production of certain substances that cause inflammation in the bowel. Because it is administered rectally, the medication works directly at the site of the inflammation to help the rectal lining heal.

Mechanism of Action

Canasa contains mesalamine, a medication that belongs to a group of drugs called aminosalicylates. It is used to treat inflammation in the rectum by acting directly on the affected tissue. While the precise way the medication works is not fully established, it is believed to reduce the production of chemicals that cause swelling and pain in the bowel lining.

Local Anti-inflammatory Effects

Unlike oral medications that travel through the entire body, Canasa is a rectal suppository designed to provide localized treatment. By applying the medication directly to the site of the disease, it helps to:

• Inhibit inflammatory substances: It may block the activity of certain enzymes and proteins that produce inflammatory markers like prostaglandins and leukotrienes.
• Reduce tissue damage: It may act as an antioxidant, neutralizing harmful molecules that can damage the cells in the rectal lining during an inflammatory flare-up.

By calming the immune response in the rectum, Canasa helps to reduce symptoms such as rectal bleeding, pain, and the frequent urge to have a bowel movement.

Common Side Effects

Many people using Canasa experience mild side effects that often resolve as the body adjusts to the medication. Common issues include:

• Rectal pain, soreness, or burning
• Stomach pain, cramping, or gas
• Nausea
• Headache
• Dizziness
• Flu-like symptoms or fever
• Acne or skin rash

Serious Side Effects

While less common, some side effects require immediate medical attention. Contact a healthcare provider right away if you experience:

• Acute Intolerance Syndrome: This condition can mimic a worsening of colitis symptoms. Seek help for severe stomach pain, cramping, bloody diarrhea, fever, headache, and rash.
• Kidney Problems: Symptoms may include changes in the frequency or amount of urination, increased thirst, or swelling in the legs and ankles.
• Liver Issues: Signs include yellowing of the eyes or skin (jaundice), dark-colored urine, or persistent nausea and vomiting.
• Heart Inflammation: Symptoms such as chest pain, a fast or pounding heartbeat, or shortness of breath.
• Severe Skin Reactions: Seek emergency care for a skin rash that involves blistering, peeling, or sores in the mouth.

This is not a complete list of all possible side effects. If you notice other symptoms, consult your doctor or pharmacist.

Hypersensitivity and Intolerance

Some patients may experience mesalamine-induced acute intolerance syndrome. This condition can be difficult to distinguish from a flare-up of ulcerative colitis. Symptoms may include:

• Abdominal pain and cramping
• Bloody diarrhea
• Fever and headache
• Rash

If these symptoms occur, treatment is typically discontinued immediately. Additionally, serious hypersensitivity reactions, such as myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the sac around the heart), have been reported.

Kidney and Liver Function

Renal impairment, including cases of kidney failure and interstitial nephritis, has been observed in patients using mesalamine products. It is generally recommended that kidney function be evaluated before starting treatment and periodically during therapy. Caution is also advised for individuals with known liver impairment, as there have been reports of hepatic failure in patients with pre-existing liver disease.

Other Precautions

• Kidney Stones: The use of mesalamine may lead to the formation of kidney stones (nephrolithiasis). Maintaining adequate fluid intake during treatment is often recommended.
• Photosensitivity: Patients with pre-existing skin conditions, such as atopic dermatitis or eczema, may experience more severe photosensitivity reactions while using this medication.
• Drug Interactions: Using mesalamine alongside certain medications, such as azathioprine or 6-mercaptopurine, may increase the risk of blood-related side effects.

Contraindications

Canasa is contraindicated in patients with a known or suspected hypersensitivity to salicylates, mesalamine, or any of the ingredients found in the suppository.

Pregnancy

There are no adequate and well-controlled studies of Canasa use in pregnant women. While animal studies using high doses of mesalamine did not show evidence of harm to the fetus, the medication is known to cross the placental barrier. Because human data is limited, Canasa should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breastfeeding

Mesalamine and its primary metabolite are excreted in human milk. There have been reports of diarrhea in infants who are breastfed by mothers taking mesalamine. If you are breastfeeding, it is important to monitor your infant for symptoms like diarrhea and discuss the risks and benefits with your healthcare provider before using this medication.

Available Forms

Canasa is provided in the following dosage form:

• Rectal Suppository: This is a solid medication designed to be inserted into the rectum. Once inserted, it melts at body temperature to deliver the active ingredient directly to the lining of the lower gastrointestinal tract.

This medication is intended for rectal use only and must not be taken by mouth.

FDA Approval and Indications

Canasa (mesalamine) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of active ulcerative proctitis. It is a localized anti-inflammatory therapy delivered directly to the rectum. The medication is available only by prescription and is intended for use in adult patients.

Boxed Warnings and REMS

Canasa does not carry any FDA boxed warnings, which are reserved for medications with the highest risk of serious or life-threatening side effects. Additionally, the FDA has not mandated a Risk Evaluation and Mitigation Strategy (REMS) for Canasa, meaning the agency has determined that the standard professional labeling provides sufficient information for its safe use.

Regulatory Safety Information

While Canasa does not have a boxed warning, the FDA-approved labeling includes several important safety precautions that healthcare providers must monitor:

• Renal Impairment: The FDA requires labeling to include warnings about potential kidney toxicity. Healthcare providers are advised to evaluate renal function prior to starting therapy and periodically during treatment.
• Mesalamine-Induced Acute Intolerance Syndrome: Regulatory information includes warnings that mesalamine may cause an acute intolerance syndrome that can be difficult to distinguish from a flare of inflammatory bowel disease.
• Hypersensitivity Reactions: The labeling includes precautions for patients with known hypersensitivity to salicylates or other components of the suppository.
• Hepatic Failure: There are reports of hepatic failure in patients with pre-existing liver disease who take mesalamine, leading to regulatory requirements for caution in these populations.

Factors Affecting Cost

Several factors influence the final price of Canasa suppositories:

• Generic vs. Brand Name: Canasa is the brand name for mesalamine. Generic versions of mesalamine rectal suppositories are available and typically cost significantly less than the brand-name product.
• Insurance Coverage: Most health insurance plans, including Medicare and Medicaid, provide coverage for mesalamine. However, the specific copay or coinsurance amount depends on the plan's formulary. Generic versions are often placed in lower cost-sharing tiers than brand-name Canasa.
• Pharmacy Choice: Prices can fluctuate between different retail pharmacies, mail-order services, and specialty pharmacies.

Financial Assistance and Savings

Patients may be able to reduce their out-of-pocket expenses through various programs:

• Manufacturer Savings: The manufacturer of brand-name Canasa may offer savings cards or coupons for eligible patients with commercial insurance.
• Patient Assistance Programs: Some programs provide medications at a lower cost or for free to individuals who meet specific income requirements and lack adequate insurance coverage.
• Generic Substitution: Choosing the generic form of mesalamine is often the most direct way to lower the cost of treatment for those without comprehensive prescription drug coverage.